Literature DB >> 11207829

Increased proliferation activities of vascular endothelial cells and tumour cells in residual hepatocellular carcinoma following transcatheter arterial embolization.

Y B Kim1, Y N Park, C Park.   

Abstract

AIMS: Transcatheter arterial embolization induces extensive ischaemic necrosis or hypoxia via the obstruction of the hepatic artery in hepatocellular carcinoma (HCC). Ischaemia is strongly correlated with an increased expression of angiogenic factor and stimulates an increase in angiogenesis, including endothelial cell proliferation. The aim of this study was to evaluate whether ischaemic necrosis induced by transcatheter arterial embolization could increase the proliferative activities of intratumoral endothelial cells or tumour cells in the residual HCC. METHODS AND
RESULTS: Using a double immunohistochemical technique (Ki67 antibody to determine the proliferative activity and CD34 antibody to highlight the intratumoral endothelial cells), we performed immunohistochemical staining for 24 HCCs treated by transcatheter arterial embolization. Seven HCCs without any preoperative transcatheter arterial embolization and nine cirrhosis cases were also studied as the control cases. The residual tumour was then divided into five areas at 0.5 mm intervals, according to the distance from the necrotic margin induced by embolization. The Ki67 labelling indices of the intratumoral endothelial cells and tumour cells were counted in each area. The correlation between the indices and the corresponding distance from the ischaemic necrosis was analysed. The Ki67 labelling index of intratumoral vascular endothelial cells in the area less than 0.5 mm from the necrotic margin (area 1) was 10.60 +/- 3.64% (mean +/- SD), which was twofold greater than those of the other areas more than 0.5 mm from the margin (areas 2--5) and those of the control HCCs without preoperative transcatheter arterial embolization. In addition, the proliferation labelling index of the tumour cells was 35.77 +/- 11.45% (mean +/- SD) in area 1. This was higher than those of areas 2--5 and control HCCs without preoperative transcatheter arterial embolization. There was a positive correlation between the proliferation of both endothelial and tumour cells and ischaemic necrosis (P < 0.05).
CONCLUSIONS: Our study suggests that the proliferative activity of intratumoral endothelial cells and tumour cells is increased by ischaemic necrosis induced by transcatheter arterial embolization, and its effect is maximal in the area adjacent to the necrosis (less than 0.5 mm from the necrotic margin).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11207829     DOI: 10.1046/j.1365-2559.2001.01064.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  21 in total

Review 1.  Current status of hepatocellular carcinoma treatment in Japan: transarterial chemoembolization.

Authors:  Osamu Matsui
Journal:  Clin Drug Investig       Date:  2012-08-08       Impact factor: 2.859

2.  Modified transarterial chemoembolization with locoregional administration of sorafenib for treating hepatocellular carcinoma: feasibility, efficacy, and safety in the VX-2 rabbit liver tumor model.

Authors:  Max Seidensticker; Sebastian Streit; Norbert Nass; Christian Wybranski; Julian Jürgens; Jan Brauner; Nadine Schulz; Thomas Kalinski; Ricarda Seidensticker; Benjamin Garlipp; Ingo Steffen; Jens Ricke; Oliver Dudeck
Journal:  Diagn Interv Radiol       Date:  2016 Jul-Aug       Impact factor: 2.630

3.  Ahypoxia-related signature enhances the prediction of the prognosis in hepatocellular carcinoma patients and correlates with sorafenib treatment response.

Authors:  Hong-Ye Jiang; Gang Ning; Yen-Sheng Wang; Wei-Biao Lv
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

4.  Chemoembolization endpoints: effect on survival among patients with hepatocellular carcinoma.

Authors:  Brian Jin; Dingxin Wang; Robert J Lewandowski; Ahsun Riaz; Robert K Ryu; Kent T Sato; Andrew C Larson; Riad Salem; Reed A Omary
Journal:  AJR Am J Roentgenol       Date:  2011-04       Impact factor: 3.959

5.  Transarterial chemoembolization alone and in combination with other therapies: a comparative study in an animal HCC model.

Authors:  A Maataoui; J Qian; D Vossoughi; M F Khan; E Oppermann; W O Bechstein; T J Vogl
Journal:  Eur Radiol       Date:  2004-12-04       Impact factor: 5.315

Review 6.  Combined interventional therapies of hepatocellular carcinoma.

Authors:  Jun Qian; Gan-Sheng Feng; Thomas Vogl
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

7.  Endostatin gene therapy for liver cancer by a recombinant adenovirus delivery.

Authors:  Li Li; Jia-Ling Huang; Qi-Cai Liu; Pei-Hong Wu; Ran-Yi Liu; Yi-Xin Zeng; Wen-Lin Huang
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

8.  Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization.

Authors:  Xiao-Feng Liao; Ji-Lin Yi; Xing-Rui Li; Wei Deng; Zhi-Fang Yang; Geng Tian
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

9.  Transarterial sorafenib chemoembolization: preliminary study of technical feasibility in a rabbit model.

Authors:  Ron C Gaba; Felix Y Yap; Elizabeth M Martinez; Yongchao Li; Grace Guzman; Ahmad Parvinian; Richard B van Breemen; Nishant Kumar
Journal:  J Vasc Interv Radiol       Date:  2013-03-17       Impact factor: 3.464

10.  Transarterial chemoembolization with/without cryotherapy is associated with improved clinical outcomes of sorafenib for the treatment of advanced hepatocellular carcinoma.

Authors:  Chunping Wang; Yinying Lu; Hong Wang; Xudong Gao; Wenlin Bai; Jianhui Qu; Guilin Xu; Zhenzhen Zhang; Zhen Zeng; Lin Zhou; Linjing An; Jiyun Lv; Yongping Yang
Journal:  Exp Ther Med       Date:  2012-05-10       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.